8-K - uniQure N.V. (0001590560) (Filer)
Published . Updated .
Key takeaways
- 8-K - uniQure N.V filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
- Exposed: QURE
- Market reaction: QURE −15.5% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - uniQure N.V filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- QURE uniQure N.V+0.7% 14d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that uniQure N.V belongs to, so it often moves with news about it.
- NVS Novartis AG-4.2% 7d
Novartis AG is a peer of uniQure N.V in pharmaceutical preparations; rivals often move on the same news.
- AZN AstraZeneca+13.7% 30d
AstraZeneca is a peer of uniQure N.V in pharmaceutical preparations; rivals often move on the same news.
- NVO Novo Nordisk A/S-0.1% 30d
Novo Nordisk A/S is a peer of uniQure N.V in pharmaceutical preparations; rivals often move on the same news.
- GSK Gsk+0.7% 5d
Gsk is a peer of uniQure N.V in pharmaceutical preparations; rivals often move on the same news.
- SNY Sanofi
Sanofi is a peer of uniQure N.V in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| QURE | -12.86% | +0.46% | base | -7.77% | -3.86% | -7.12% | -15.49% |
| XLV | -3.03% | -2.77% | base | -0.14% | -0.48% | +2.59% | +0.17% |
| NVS | -4.37% | -2.94% | base | +0.39% | -0.98% | +2.61% | +0.59% |
| AZN | -7.79% | -9.17% | base | -0.02% | -1.47% | +1.27% | +0.29% |
| NVO | -2.16% | -4.29% | base | +1.15% | +0.54% | +5.44% | +0.18% |
| GSK | +3.20% | -1.53% | base | -0.79% | -1.58% | +3.29% | +1.72% |
| SNY | -5.83% | -4.80% | base | +2.61% | +2.15% | +6.92% | +5.33% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-02 AccNo: 0001104659-26-120915 Size: 228 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 2 Nov 2026: uniQure N.V (QURE) versus the S&P 500
Since the first closing price after “8-K - uniQure N.V. (0001590560) (Filer),” uniQure N.V (QURE) is +3.14%.
| Company | When | Move | Status |
|---|---|---|---|
| AZN | that day | -0.02% | final price |
| AZN | the next day | -1.47% | final price |
| AZN | two days later | +1.27% | final price |
| AZN | three days later | +0.29% | final price |
| AZN | three days earlier | -9.17% | final price |
| AZN | five days earlier | -7.79% | final price |
| GSK | that day | -0.79% | final price |
| GSK | the next day | -1.58% | final price |
| GSK | two days later | +3.29% | final price |
| GSK | three days later | +1.72% | final price |
| GSK | three days earlier | -1.53% | final price |
| GSK | five days earlier | +3.20% | final price |
| NVO | that day | +1.15% | final price |
| NVO | the next day | +0.54% | final price |
| NVO | two days later | +5.44% | final price |
| NVO | three days later | +0.18% | final price |
| NVO | three days earlier | -4.29% | final price |
| NVO | five days earlier | -2.16% | final price |
| NVS | that day | +0.39% | final price |
| NVS | the next day | -0.98% | final price |
| NVS | two days later | +2.61% | final price |
| NVS | three days later | +0.59% | final price |
| NVS | three days earlier | -2.94% | final price |
| NVS | five days earlier | -4.37% | final price |
| uniQure N.V (QURE) | that day | -7.77% | final price |
| uniQure N.V (QURE) | the next day | -3.86% | final price |
| uniQure N.V (QURE) | two days later | -7.12% | final price |
| uniQure N.V (QURE) | three days later | -15.49% | final price |
| uniQure N.V (QURE) | three days earlier | +0.46% | final price |
| uniQure N.V (QURE) | five days earlier | -12.86% | final price |
| SNY | that day | +2.61% | final price |
| SNY | the next day | +2.15% | final price |
| SNY | two days later | +6.92% | final price |
| SNY | three days later | +5.33% | final price |
| SNY | three days earlier | -4.80% | final price |
| SNY | five days earlier | -5.83% | final price |
| XLV | that day | -0.14% | final price |
| XLV | the next day | -0.48% | final price |
| XLV | two days later | +2.59% | final price |
| XLV | three days later | +0.17% | final price |
| XLV | three days earlier | -2.77% | final price |
| XLV | five days earlier | -3.03% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Novartis Ag (NVS), worth $15,001 - $50,000 on 27 Aug 2026. That is 67 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 10 Sep 2026. That is 53 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 31 Aug 2026. That is 63 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Scott Scott Franklin bought Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 26 Aug 2026. That is 68 days before publication. Filed 17 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - uniQure N.V. (0001590560) (Filer)”
Companies carried with this story
- QURE uniQure N.V
For “8-K - uniQure N.V. (0001590560) (Filer),” uniQure N.V (QURE) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> QURE
How “8-K - uniQure N.V. (0001590560) (Filer)” reaches uniQure N.V (QURE)
“8-K - uniQure N.V. (0001590560) (Filer)” (2 Nov 2026) reaches uniQure N.V (QURE) through this story.
The link for uniQure N.V (QURE) is this: SEC 8-K filing -> direct issuer disclosure -> QURE
The price range for uniQure N.V (QURE), and the dates in the story
QURE traded between 20.59 and 26.63 across 14 sessions. The latest close on file is 24.64.
How solid “8-K - uniQure N.V. (0001590560) (Filer)” looks
14 out of 100
“8-K - uniQure N.V. (0001590560) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.